Companies /Healthcare

DFTX

DFTX Biotechnology
Today · % change

Fundamentals

Market Cap
$5.5B
EPS (TTM)
$-3.43
52-Week Range
$9 – $50
Street Target
$67.47

About DFTX

Definium Therapeutics, Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company is headquartered in New York, New York.

DFTX Coverage